HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 296/6/F1417    most recent 90337.2008v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Liu, L. Articles by Eaton, D. C. PubMed PubMed Citation Articles by Liu, L. Articles by Eaton, D. C.

Biphasic regulation of ENaC by TGF- and EGF in renal epithelial cells

Center For Cell and Molecular Signaling, Department of Physiology, Emory University School of Medicine, Atlanta, Georgia

Submitted 30 May 2008 ; accepted in final form 12 March 2009

The epithelial sodium channel (ENaC) is regulated by epidermal growth factor (EGF). We investigate whether ENaC is regulated by another EGF receptor (EGFR) ligand, transforming growth factor- (TGF-). We show that chronic (24 h) treatment with TGF- inhibits ENaC in Xenopus laevis kidney cells 20 times more strongly than EGF. By using single-channel measurements, we show that TGF- significantly reduces the number of ENaC per patch. The open probability (P_o) is unchanged by 24-h treatment with TGF-. -, β-, and -ENaC mRNA levels are significantly reduced by TGF- or EGF. TGF- or EGF reduces - and -ENaC proteins in the membrane; however, β-ENaC is unchanged. TGF- or EGF inhibits ENaC by activating EGFR since the EGFR inhibitor AG1478 blocks the effects of both. The MAPK 1/2 inhibitor U0126 also blocks the effect of TGF- or EGF on ENaC, indicating that the MAPK1/2 pathway is involved in the TGF-- or EGF-induced inhibition of ENaC. Interestingly, acute treatment (<1 h) with TGF- or EGF does not inhibit ENaC current; it enhances ENaC activity by increasing P_o. Pretreatment of the cells with U0126 potentiates the acute TGF-- or EGF-induced stimulation of ENaC. This TGF-- or EGF-induced increase in sodium current is abolished by a phosphatidylinositol 3-kinase (PI-3 kinase) inhibitor, LY294002, suggesting that PI-3 kinase is involved in the activation of sodium transport. In conclusion, chronic treatment with TGF- or EGF inhibits ENaC by decreasing the number of channels in the membrane transcriptionally through MAPK1/2 pathways, but acute treatment with TGF- or EGF activates ENaC by increasing P_o via PI-3 kinase.

sodium transport; EGFR; kidney